Deutsche Bank downgrades Select Medical stock on acquisition agreement
Entity Intersection Graph
No entity connections available yet for this article.
Original Source
try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry Oil prices surge higher as conflict threatens supply; Goldman lifts forecasts South Korean stock trading temporarily halted as KOSPI slides over 11% Goldman lifts oil price forecast amid Hormuz disruptions, lower inventories Stocks close in the red as widening Middle East conflict sparks inflation fears (South Africa Philippines Nigeria) Deutsche Bank downgrades Select Medical stock on acquisition agreement By Analyst Ratings Published 03/04/2026, 04:01 AM Deutsche Bank downgrades Select Medical stock on acquisition agreement 0 SEM 8.40% Investing.com - Deutsche Bank downgraded Select Medical Holdings (NYSE:SEM) to Hold from Buy on Monday, raising its price target to $16.50 from $16.20. The downgrade follows Select Medical entering a definitive agreement to be acquired. Analyst Justin Bowers cited the stock’s recent performance as a factor in the rating change. Select Medical shares have risen 16% since the November 24, 2025 closing price, the day before the initial take-private proposal was announced. This represents a 68% annualized gain through the March 3 close. The stock, currently trading at $16.26 with a market cap of $2.1 billion, has delivered a 9.6% return over the past week and 26% over six months. According to InvestingPro analysis, the company remains undervalued based on its Fair Value assessment, with analysts recently revising earnings estimates upward. Investors can access 4 additional InvestingPro Tips and a comprehensive Pro Research Report for deeper insights into SEM’s acquisition potential. Shareholders who retained ownership of both Select Medical and Concentra have generated a 69% return to date. This return is measured against Select Medical’s pre-spin valuation on January 3, 2024. January 3, 2024 marked the day before Select Medical announced its intent to spin off Concentra, which Deutsche Bank identified as the beginning of its Value with a Catalyst series. In other recent news, Se...
Read full article at source